CN112451637A - Traditional Chinese medicine preparation for treating myocardial ischemia - Google Patents

Traditional Chinese medicine preparation for treating myocardial ischemia Download PDF

Info

Publication number
CN112451637A
CN112451637A CN202011263600.9A CN202011263600A CN112451637A CN 112451637 A CN112451637 A CN 112451637A CN 202011263600 A CN202011263600 A CN 202011263600A CN 112451637 A CN112451637 A CN 112451637A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
medicine preparation
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011263600.9A
Other languages
Chinese (zh)
Inventor
付强
莫陶然
付殷
胡晓阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang University of Chinese Medicine
Original Assignee
Heilongjiang University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilongjiang University of Chinese Medicine filed Critical Heilongjiang University of Chinese Medicine
Priority to CN202011263600.9A priority Critical patent/CN112451637A/en
Publication of CN112451637A publication Critical patent/CN112451637A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9064—Amomum, e.g. round cardamom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine preparation for treating myocardial ischemia, wherein the raw materials of the traditional Chinese medicine preparation comprise 5-10 parts of panax notoginseng saponins, 10-15 parts of salvianolate, 5-10 parts of ligustrazine, 10-15 parts of ginseng, 5-10 parts of leech, 10-15 parts of frankincense, 20-25 parts of borneol, 20-25 parts of spina date seed, 10-15 parts of calculus bovis factitius, 10-15 parts of angelica, 10-15 parts of astragalus membranaceus, 10-15 parts of musk, 15-20 parts of venenum bufonis, 10-15 parts of dragon's blood, 10-15 parts of caulis spatholobi, 10-15 parts of rhizoma corydalis, 30-35 parts of polygonum multiflorum, 20-25 parts of rhizoma polygonati, 15-20 parts of radix puerariae, 10-15 parts of elecampane, 40-45 parts of donkey-hide, 15-20 parts of rhizoma pinelliae preparata, 20-25 parts of semen coicis, 30-35 parts of pericarpium citri reticulatae, 20-25 parts of poria cocos, 10-15 parts of fructus amomi, 10-15 parts of radix paeoniae rubra, 10-15 parts of sandalwood, 10-15 parts of fructus aurantii, 20-25 parts of radix bupleuri, 30-35 parts of radix curcumae, 20-25 parts of rhizoma corydalis, 10-15 parts of codonopsis pilosula and 30-35 parts of radix ophiopogonis, accords with the theories of traditional Chinese medicine and modern medicine, has the effects of activating blood circulation to dissipate blood stasis, tonifying spleen to relieve pain, clearing heat and eliminating evil, and has a remarkable curative effect of treating myocardial.

Description

Traditional Chinese medicine preparation for treating myocardial ischemia
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine preparation for treating myocardial ischemia.
Background
Myocardial ischemic disease is a common disease, is mostly caused in middle-aged and elderly people, and is the most common reason for temporary loss of labor capacity and premature disability of people with labor capacity. The basic symptoms are precordial discomfort, dull pain, palpitation, shortness of breath, chest distress, mental fatigue, easy fatigue, muscle soreness of the whole body, arrhythmia and the like. The traditional Chinese medicine considers that the disease is related to heart blood deficiency, qi deficiency and blood stasis, and pathogenic heat disturbing the heart. The onset of myocardial ischemic diseases increases with age, and the degree of ischemic diseases also increases with age. There are data showing that the prevalence of myocardial ischemic disease increases 1-fold for every 10 years of age from 40 years of age. Coronary arteriosclerosis develops rapidly in men 50 years old and women 60 years old, and the risk of myocardial infarction increases with age.
At present, a plurality of medicines for treating myocardial ischemia exist, and the myocardial ischemia can be treated by an operation. However, the risk of surgery is not negligible, so that the general patients with myocardial ischemia will not select surgery treatment without serious problems. The domestic common medicines mainly comprise: antiplatelet drugs (such as aspirin and clopidogrel) can be used for preventing and treating thrombosis, and preventing thromboembolism of coronary artery and cerebral artery; beta-receptor blockers (e.g., metoprolol or sustained release tablets) that slow heart rate and reduce myocardial consumption and oxygen consumption, preventing sudden death; calcium ion antagonists and the like, although the drugs have quick effect, the drugs can not achieve the purpose of radical treatment, because the coronary artery of the heart can not expand infinitely, that is, the western medicines are eaten more, the coronary artery can generate drug resistance, and the effect is reduced. Moreover, western medicines have side effects and can damage other organs of the body after long-term administration. Therefore, in order to better guarantee the life health and safety of patients, the holistic concept of traditional Chinese medicine and the advantages of dialectical treatment should be brought into play, and a traditional Chinese medicine prescription for effectively treating myocardial ischemia is found.
Disclosure of Invention
To solve the problems set forth in the background art described above. The invention provides a traditional Chinese medicine preparation for treating myocardial ischemia, which has the characteristics of short treatment course, quick response, low cost, no toxic or side effect and treatment of both symptoms and root causes.
In order to achieve the purpose, the invention provides the following technical scheme: a traditional Chinese medicine preparation for treating myocardial ischemia comprises traditional Chinese medicine preparation raw materials, wherein the traditional Chinese medicine preparation raw materials comprise 5-10 parts of panax notoginseng saponins, 10-15 parts of salvianolate, 5-10 parts of ligustrazine, 10-15 parts of ginseng, 5-10 parts of leech, 10-15 parts of frankincense, 20-25 parts of borneol, 20-25 parts of spina date seed, 10-15 parts of calculus bovis factitious, 10-15 parts of angelica, 10-15 parts of astragalus membranaceus, 10-15 parts of musk, 15-20 parts of toad venom, 10-15 parts of dragon's blood, 10-15 parts of suberect spatholobus stem, 10-15 parts of corydalis tuber, 30-35 parts of polygonum multiflorum, 20-25 parts of rhizoma polygonati, 15-20 parts of radix puerariae, 10-15 parts of costustoot, 40-45 parts of donkey-hide gelatin, 20-25 parts of, 15-20 parts of rhizoma pinelliae preparata, 20-25 parts of semen coicis, 30-35 parts of dried orange peel, 20-25 parts of poria cocos, 10-15 parts of fructus amomi, 10-15 parts of red paeony root, 10-15 parts of sandalwood, 10-15 parts of fructus aurantii, 20-25 parts of radix bupleuri, 30-35 parts of radix curcumae, 20-25 parts of rhizoma corydalis, 10-15 parts of codonopsis pilosula and 30-35 parts of radix ophiopogonis.
Preferably, the raw materials of the various medicinal preparations comprise, by weight, 5 parts of panax notoginseng saponins, 10 parts of salvianolate, 5 parts of ligustrazine, 10 parts of ginseng, 5 parts of leech, 10 parts of frankincense, 20 parts of borneol, 20 parts of spina date seed, 10 parts of calculus bovis factitius, 10 parts of angelica, 10 parts of astragalus membranaceus, 10 parts of musk, 15 parts of venenum bufonis, 10 parts of dragon's blood, 10 parts of caulis spatholobi, 10 parts of rhizoma corydalis, 30 parts of polygonum multiflorum, 20 parts of rhizoma polygonati, 15 parts of radix puerariae, 10 parts of costus root, 40 parts of donkey-hide gelatin, 20 parts of water caltrop peel, 10 parts of allium macrostemon, 15 parts of rhizoma pinelliae preparata, 20 parts of semen coicis, 30 parts of pericarpium citri reticulatae, 20 parts of poria cocos, 10 parts of fructus amomi, 10 parts of radix paeoniae.
Preferably, the raw materials of the various medicinal preparations comprise, by weight, 6 parts of panax notoginseng saponins, 11 parts of salvianolate, 6 parts of ligustrazine, 11 parts of ginseng, 6 parts of leech, 11 parts of frankincense, 21 parts of borneol, 21 parts of spina date seed, 11 parts of calculus bovis factitius, 11 parts of angelica, 11 parts of astragalus membranaceus, 11 parts of musk, 16 parts of venenum bufonis, 11 parts of dragon's blood, 11 parts of caulis spatholobi, 11 parts of rhizoma corydalis, 31 parts of polygonum multiflorum, 21 parts of rhizoma polygonati, 16 parts of radix puerariae, 11 parts of costus root, 41 parts of donkey-hide gelatin, 21 parts of water caltrop peel, 11 parts of allium macrostemon, 16 parts of rhizoma pinelliae preparata, 21 parts of semen coicis, 31 parts of dried orange peel, 21 parts of poria cocos, 11 parts of fructus amomi, 11 parts of red paeony root.
Preferably, the raw materials of the various medicinal preparations comprise, by weight, 7 parts of panax notoginseng saponins, 12 parts of salvianolate, 7 parts of ligustrazine, 12 parts of ginseng, 7 parts of leech, 12 parts of frankincense, 22 parts of borneol, 22 parts of spina date seed, 12 parts of calculus bovis factitius, 12 parts of angelica, 12 parts of astragalus membranaceus, 12 parts of musk, 17 parts of venenum bufonis, 12 parts of dragon's blood, 12 parts of caulis spatholobi, 12 parts of rhizoma corydalis, 32 parts of polygonum multiflorum, 22 parts of rhizoma polygonati, 17 parts of radix puerariae, 12 parts of costus root, 42 parts of donkey-hide gelatin, 22 parts of water caltrop peel, 12 parts of allium macrostemon, 17 parts of rhizoma pinelliae preparata, 22 parts of semen coicis, 32 parts of dried orange peel, 22 parts of poria cocos, 12 parts of fructus amomi, 12 parts of red paeony root.
Preferably, the raw materials of each medicinal preparation comprise, by weight, 8 parts of panax notoginseng saponins, 13 parts of salvianolate, 8 parts of ligustrazine, 13 parts of ginseng, 8 parts of leech, 13 parts of frankincense, 23 parts of borneol, 23 parts of spina date seed, 13 parts of calculus bovis factitius, 13 parts of angelica, 13 parts of astragalus membranaceus, 13 parts of musk, 18 parts of venenum bufonis, 13 parts of dragon's blood, 13 parts of caulis spatholobi, 13 parts of rhizoma corydalis, 33 parts of polygonum multiflorum, 23 parts of rhizoma polygonati, 18 parts of radix puerariae, 13 parts of elecampane, 43 parts of donkey-hide gelatin, 23 parts of water chestnut skin, 13 parts of allium macrostemon, 18 parts of rhizoma pinelliae preparata, 23 parts of semen coicis, 33 parts of pericarpium citri reticulatae, 23 parts of poria cocos, 13 parts of fructus amomi, 13 parts of radix paeoniae rubra.
Preferably, the raw materials of the various medicinal preparations comprise, by weight, 9 parts of panax notoginseng saponins, 14 parts of salvianolate, 9 parts of ligustrazine, 14 parts of ginseng, 9 parts of leech, 14 parts of frankincense, 24 parts of borneol, 24 parts of spina date seed, 14 parts of calculus bovis factitius, 14 parts of angelica, 14 parts of astragalus membranaceus, 14 parts of musk, 19 parts of venenum bufonis, 14 parts of dragon's blood, 14 parts of caulis spatholobi, 14 parts of rhizoma corydalis, 34 parts of polygonum multiflorum, 24 parts of rhizoma polygonati, 19 parts of radix puerariae, 14 parts of elecampane, 44 parts of donkey-hide gelatin, 24 parts of water chestnut skin, 14 parts of allium macrostemon, 19 parts of rhizoma pinelliae preparata, 24 parts of semen coicis, 34 parts of pericarpium citri reticulatae, 24 parts of poria cocos, 14 parts of fructus amomi, 14 parts of radix paeoniae rubra.
Preferably, the raw materials of each medicinal preparation comprise, by weight, 10 parts of panax notoginseng saponins, 15 parts of salvianolate, 10 parts of ligustrazine, 15 parts of ginseng, 10 parts of leech, 15 parts of frankincense, 25 parts of borneol, 25 parts of spina date seed, 15 parts of calculus bovis factitius, 15 parts of angelica, 15 parts of astragalus membranaceus, 15 parts of musk, 20 parts of venenum bufonis, 15 parts of dragon's blood, 15 parts of caulis spatholobi, 15 parts of rhizoma corydalis, 35 parts of polygonum multiflorum, 25 parts of rhizoma polygonati, 20 parts of radix puerariae, 15 parts of costus root, 45 parts of donkey-hide gelatin, 25 parts of water caltrop peel, 15 parts of allium macrostemon, 20 parts of rhizoma pinelliae preparata, 25 parts of semen coicis, 35 parts of pericarpium citri reticulatae, 25 parts of poria cocos, 15 parts of fructus amomi, 15 parts of radix paeoniae rubr.
Preferably, the raw materials of the medicinal preparation are selected according to different parts by weight according to the degree of illness, the medicinal materials are taken and cleaned, all the medicinal materials are decocted according to the proportion, the decoction is taken, 1 dose is taken every day and is orally taken for 2-3 times, 20 doses are 1 course of treatment, the medicine is stopped for 2-3 days in the course of treatment, and then the next 1 course of treatment is carried out.
The invention has the beneficial effects that: the traditional Chinese medicine preparation disclosed by the invention has the advantages of appropriate compatibility of selected medicinal materials, accordance with the theories of traditional Chinese medicine and modern medicine, effects of promoting blood circulation to remove blood stasis, invigorating spleen to relieve pain, clearing heat and eliminating evil, obvious curative effect on treating myocardial ischemia caused by various symptoms, short treatment course, quick response, low cost, no toxic or side effect, treatment of both symptoms and root causes, and clinical application and popularization deserving of being worthy of.
Detailed Description
All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides the following technical scheme: a traditional Chinese medicine preparation for treating myocardial ischemia comprises traditional Chinese medicine preparation raw materials, wherein the traditional Chinese medicine preparation raw materials comprise 5-10 parts of panax notoginseng saponins, 10-15 parts of salvianolate, 5-10 parts of ligustrazine, 10-15 parts of ginseng, 5-10 parts of leech, 10-15 parts of frankincense, 20-25 parts of borneol, 20-25 parts of spina date seed, 10-15 parts of calculus bovis factitious, 10-15 parts of angelica, 10-15 parts of astragalus membranaceus, 10-15 parts of musk, 15-20 parts of toad venom, 10-15 parts of dragon's blood, 10-15 parts of suberect spatholobus stem, 10-15 parts of corydalis tuber, 30-35 parts of polygonum multiflorum, 20-25 parts of rhizoma polygonati, 15-20 parts of radix puerariae, 10-15 parts of costustoot, 40-45 parts of donkey-hide gelatin, 20-25 parts of, 15-20 parts of rhizoma pinelliae preparata, 20-25 parts of semen coicis, 30-35 parts of dried orange peel, 20-25 parts of poria cocos, 10-15 parts of fructus amomi, 10-15 parts of red paeony root, 10-15 parts of sandalwood, 10-15 parts of fructus aurantii, 20-25 parts of radix bupleuri, 30-35 parts of radix curcumae, 20-25 parts of rhizoma corydalis, 10-15 parts of codonopsis pilosula and 30-35 parts of radix ophiopogonis.
The traditional Chinese medicine preparation for treating myocardial ischemia has the following effects:
Figure RE-GDA0002918086640000051
Figure RE-GDA0002918086640000061
Figure RE-GDA0002918086640000071
Figure RE-GDA0002918086640000081
example 1
The proportion of the medicinal materials used by patients with mild disease is as follows:
specifically, the raw materials of the various medicinal preparations comprise, by weight, 5 parts of panax notoginseng saponins, 10 parts of salvianolate, 5 parts of ligustrazine, 10 parts of ginseng, 5 parts of leech, 10 parts of frankincense, 20 parts of borneol, 20 parts of spina date seed, 10 parts of calculus bovis factitius, 10 parts of angelica, 10 parts of astragalus membranaceus, 10 parts of musk, 15 parts of venenum bufonis, 10 parts of dragon's blood, 10 parts of caulis spatholobi, 10 parts of rhizoma corydalis, 30 parts of polygonum multiflorum, 20 parts of rhizoma polygonati, 15 parts of radix puerariae, 10 parts of elecampane, 40 parts of donkey-hide gelatin, 20 parts of water chestnut skin, 10 parts of allium macrostemon, 15 parts of rhizoma pinelliae preparata, 20 parts of semen coicis, 30 parts of pericarpium citri reticulatae, 20 parts of poria cocos, 10 parts of fructus amomi, 10 parts of radix paeoniae rubra.
Example 2
The proportion of the medicinal materials used by the patients with mild illness is as follows:
specifically, the raw materials of the various medicinal preparations comprise, by weight, 6 parts of panax notoginseng saponins, 11 parts of salvianolate, 6 parts of ligustrazine, 11 parts of ginseng, 6 parts of leech, 11 parts of frankincense, 21 parts of borneol, 21 parts of spina date seed, 11 parts of calculus bovis factitius, 11 parts of angelica, 11 parts of astragalus membranaceus, 11 parts of musk, 16 parts of venenum bufonis, 11 parts of dragon's blood, 11 parts of caulis spatholobi, 11 parts of rhizoma corydalis, 31 parts of polygonum multiflorum, 21 parts of rhizoma polygonati, 16 parts of radix puerariae, 11 parts of costus root, 41 parts of donkey-hide gelatin, 21 parts of water caltrop peel, 11 parts of allium macrostemon, 16 parts of rhizoma pinelliae preparata, 21 parts of semen coicis, 31 parts of pericarpium citri reticulatae, 21 parts of poria cocos, 11 parts of fructus amomi, 11 parts of radix paeoniae.
Example 3
The proportion of the medicinal materials used by the middle-aged patients is as follows:
specifically, the raw materials of the various medicinal preparations comprise, by weight, 7 parts of panax notoginseng saponins, 12 parts of salvianolate, 7 parts of ligustrazine, 12 parts of ginseng, 7 parts of leech, 12 parts of frankincense, 22 parts of borneol, 22 parts of spina date seed, 12 parts of calculus bovis factitius, 12 parts of angelica, 12 parts of astragalus membranaceus, 12 parts of musk, 17 parts of venenum bufonis, 12 parts of dragon's blood, 12 parts of caulis spatholobi, 12 parts of rhizoma corydalis, 32 parts of polygonum multiflorum, 22 parts of rhizoma polygonati, 17 parts of radix puerariae, 12 parts of costus root, 42 parts of donkey-hide gelatin, 22 parts of water caltrop peel, 12 parts of allium macrostemon, 17 parts of rhizoma pinelliae preparata, 22 parts of semen coicis, 32 parts of pericarpium citri reticulatae, 22 parts of poria cocos, 12 parts of fructus amomi, 12 parts of radix paeoniae.
Example 4
The proportion of the medicinal materials used by the middle-aged and the senior patients is as follows:
specifically, the raw materials of each medicinal preparation comprise, by weight, 8 parts of panax notoginseng saponins, 13 parts of salvianolate, 8 parts of ligustrazine, 13 parts of ginseng, 8 parts of leech, 13 parts of frankincense, 23 parts of borneol, 23 parts of spina date seed, 13 parts of calculus bovis factitius, 13 parts of angelica, 13 parts of astragalus membranaceus, 13 parts of musk, 18 parts of venenum bufonis, 13 parts of dragon's blood, 13 parts of caulis spatholobi, 13 parts of rhizoma corydalis, 33 parts of polygonum multiflorum, 23 parts of rhizoma polygonati, 18 parts of radix puerariae, 13 parts of elecampane, 43 parts of donkey-hide gelatin, 23 parts of water chestnut skin, 13 parts of allium macrostemon, 18 parts of rhizoma pinelliae preparata, 23 parts of semen coicis, 33 parts of pericarpium citri reticulatae, 23 parts of poria cocos, 13 parts of fructus amomi, 13 parts of radix paeoniae rubra.
Example 5
The proportion of the medicinal materials for the patient with serious illness is as follows:
specifically, the raw materials of the various medicinal preparations comprise, by weight, 9 parts of panax notoginseng saponins, 14 parts of salvianolate, 9 parts of ligustrazine, 14 parts of ginseng, 9 parts of leech, 14 parts of frankincense, 24 parts of borneol, 24 parts of spina date seed, 14 parts of calculus bovis factitius, 14 parts of angelica, 14 parts of astragalus membranaceus, 14 parts of musk, 19 parts of venenum bufonis, 14 parts of dragon's blood, 14 parts of caulis spatholobi, 14 parts of rhizoma corydalis, 34 parts of polygonum multiflorum, 24 parts of rhizoma polygonati, 19 parts of radix puerariae, 14 parts of elecampane, 44 parts of donkey-hide gelatin, 24 parts of water chestnut skin, 14 parts of allium macrostemon, 19 parts of rhizoma pinelliae preparata, 24 parts of semen coicis, 34 parts of pericarpium citri reticulatae, 24 parts of poria cocos, 14 parts of fructus amomi, 14 parts of radix paeoniae rubra.
Example 6
The proportion of the medicinal materials for patients with high or severe disease is as follows:
specifically, the raw materials of each medicinal preparation comprise, by weight, 10 parts of panax notoginseng saponins, 15 parts of salvianolate, 10 parts of ligustrazine, 15 parts of ginseng, 10 parts of leech, 15 parts of frankincense, 25 parts of borneol, 25 parts of spina date seed, 15 parts of calculus bovis factitius, 15 parts of angelica, 15 parts of astragalus membranaceus, 15 parts of musk, 20 parts of venenum bufonis, 15 parts of dragon's blood, 15 parts of caulis spatholobi, 15 parts of rhizoma corydalis, 35 parts of polygonum multiflorum, 25 parts of rhizoma polygonati, 20 parts of radix puerariae, 15 parts of elecampane, 45 parts of donkey-hide gelatin, 25 parts of water chestnut skin, 15 parts of allium macrostemon, 20 parts of rhizoma pinelliae preparata, 25 parts of semen coicis, 35 parts of pericarpium citri reticulatae, 25 parts of poria cocos, 15 parts of fructus amomi, 15 parts of radix paeoniae rubra.
The curative effect of the traditional Chinese medicine preparation is further verified by specific cases as follows:
in the past of 50 years, patients with myocardial ischemia have a history of 1 year, and the symptoms of pain, stuffiness in the heart, chest distress, fatigue, hypodynamia, poor sleep and appetite and the like often appear, and the mental state is cachexia. Once taking the medicines of salvia miltiorrhiza tablet, Di' ao Xinxuekang, Xiaoxin tong and the like, the medicine has quick onset of action, but is easy to repeat, the curative effect is gradually reduced, and the symptom shows aggravation; thus, under the recommendation of friends, the traditional Chinese medicine is tried to be used for treatment, 8 parts of panax notoginseng saponins, 13 parts of salvianolate, 8 parts of ligustrazine, 13 parts of ginseng, 8 parts of leech, 13 parts of frankincense, 23 parts of borneol, 23 parts of spina date seed, 13 parts of calculus bovis factitius, 13 parts of angelica, 13 parts of astragalus, 13 parts of musk, 18 parts of venenum bufonis, 13 parts of dragon's blood, 13 parts of caulis spatholobi, 13 parts of corydalis tuber, 33 parts of polygonum multiflorum, 23 parts of rhizoma polygonati, 18 parts of radix puerariae, 13 parts of costus root, 43 parts of donkey-hide gelatin, 23 parts of water caltrop skin, 13 parts of allium macrostemon, 18 parts of rhizoma pinelliae preparata, 23 parts of semen coicis, 33 parts of dried orange peel, 23 parts of poria cocos, 13 parts of fructus amomi, 13 parts of red paeony root, 13 parts of sandalwood, 13 parts of fructus. After a treatment course, the number of heartache attacks of a patient is reduced, the mental state is improved, and the patient starts to feel full of strength; after a course of treatment, symptoms such as cardiodynia, chest distress and the like disappear, the electrocardiographic examination returns to normal, but physical labor cannot be carried out yet, so that after a course of treatment is continued for consolidation treatment, the patient returns to health, and no relapse occurs in follow-up visit for one year.
Zhangzhi, male 52, the patient often feels chest distress, chest pain, dizziness and sometimes blackened eyes without obvious inducement before one year, the patient goes to hospital to check and finds that the heart skips slowly, even occasionally has the phenomenon of cardiac arrest, the diagnosis shows that the symptoms are caused by myocardial ischemia, and the doctor recommends the operation treatment. However, the patients insist on the traditional Chinese medicine conditioning treatment, and then the patients recommend to begin to take the traditional Chinese medicine. Taking 7 parts of panax notoginseng saponins, 12 parts of salvianolate, 7 parts of ligustrazine, 12 parts of ginseng, 7 parts of leech, 12 parts of frankincense, 22 parts of borneol, 22 parts of spina date seed, 12 parts of calculus bovis factitius, 12 parts of angelica, 12 parts of astragalus, 12 parts of musk, 17 parts of toad venom, 12 parts of dragon's blood, 12 parts of suberect spatholobus stem, 12 parts of corydalis tuber, 32 parts of tuber fleeceflower root, 22 parts of rhizoma polygonati, 17 parts of kudzu-vine root, 12 parts of costustoot, 42 parts of donkey-hide gelatin, 22 parts of water chestnut skin, 12 parts of allium macrostemon, 17 parts of rhizoma pinelliae preparata, 22 parts of coix seed, 32 parts of dried orange peel, 22 parts of poria cocos, 12 parts of fructus amomi, 12 parts of red paeony root, 12 parts of sandalwood, 12 parts of fructus aurantii, 22 parts of radix bupleuri, 32 parts of radix curcumae, 22 parts of rhizoma corydalis, 12 parts of codonopsis pilosula, 32 parts of dwarf lilyturf tuber, 18 parts, 14 parts of costustoot, 14 parts of musk, 18 parts of rhizoma polygonati, 7 parts of dragon's blood, 18 parts of cherokee rose fruit, 14 parts of fleece-flower root, 14 parts of cinnamon and 7 parts of dalbergia wood are decocted with water for taking 1 dose a day, and the medicine is taken warm twice in the morning and at night. After one treatment course, the patient can be better in chest distress and suffocation, the times of dizziness and pre-ocular blackening are reduced, and after two treatment courses, the patient only suffers from headache once during the period, and the chest distress and suffocation symptom disappears. After the medicine is continuously taken for 1 month for consolidation, the medicine is stopped, and no relapse occurs after 2 years of follow-up visit.
Li Yi 65 Men, patients had coronary disease and myocardial ischemia history for 7 years, and had symptoms of pain, stuffiness and hardness in heart, chest distress, fatigue, debilitation, poor sleep and food intake, etc., and listlessness. The treatment is carried out for many times in hospitals, but the effect is not obvious, and the patients lose confidence. Chance is recommended by friends to try to use the recipe for conditioning treatment. Observing symptoms of a patient, identifying yang deficiency cold phlegm, taking 10 parts of panax notoginseng saponins, 15 parts of salvianolate, 10 parts of ligustrazine, 15 parts of ginseng, 10 parts of leech, 15 parts of frankincense, 25 parts of borneol, 25 parts of spina date seed, 15 parts of calculus bovis factitius, 15 parts of angelica, 15 parts of astragalus, 15 parts of musk, 20 parts of venenum bufonis, 15 parts of dragon's blood, 15 parts of caulis spatholobi, 15 parts of rhizoma corydalis, 35 parts of polygonum multiflorum, 25 parts of rhizoma polygonati, 20 parts of radix puerariae, 15 parts of elecampane, 45 parts of donkey-hide gelatin, 25 parts of water caltrop skin, 15 parts of allium macrostemon, 20 parts of rhizoma pinelliae preparata, 25 parts of semen coicis, 35 parts of pericarpium citri reticulatae, 25 parts of poria cocos, 15 parts of fructus amomi, 15 parts of red paeony root, 15 parts of sandalwood, 15 parts of fructus aurantii, 25. After a treatment course, the number of heartache attacks of a patient is reduced, the mental state is improved, and the patient starts to feel full of strength; after a course of treatment, symptoms such as cardiodynia, chest distress and the like disappear, the electrocardiographic examination returns to normal, but physical labor cannot be carried out yet, so that after a course of treatment is continued for consolidation treatment, the patient returns to health, and no relapse occurs in follow-up visit for one year.
The working principle and the using process of the invention are as follows: selecting different raw materials of the medicinal preparation according to the degree of illness, taking the medicinal materials, cleaning, decocting all the medicinal materials according to the proportion, taking decoction, taking 1 dose per day, taking the decoction for 2-3 times of oral administration, taking 20 doses for 1 course of treatment, stopping taking the decoction for 2-3 days in the course of treatment, and then carrying out the next 1 course of treatment.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (7)

1. A traditional Chinese medicine preparation for treating myocardial ischemia is characterized in that: comprises the raw materials of a traditional Chinese medicine preparation, the raw materials of the traditional Chinese medicine preparation comprise 5-10 parts of panax notoginseng saponins, 10-15 parts of salvianolate, 5-10 parts of ligustrazine, 10-15 parts of ginseng, 5-10 parts of leech, 10-15 parts of frankincense, 20-25 parts of borneol, 20-25 parts of spina date seed, 10-15 parts of calculus bovis factitius, 10-15 parts of angelica, 10-15 parts of astragalus root, 10-15 parts of musk, 15-20 parts of toad venom, 10-15 parts of dragon's blood, 10-15 parts of suberect spatholobus stem, 10-15 parts of corydalis tuber, 30-35 parts of tuber fleeceflower root, 20-25 parts of rhizoma polygonati, 15-20 parts of kudzu-vine root, 10-15 parts of costustoot, 40-45 parts of donkey-hide gelatin, 20-25 parts of water caltrop peel, 10-15, 30-35 parts of dried orange peel, 20-25 parts of poria cocos, 10-15 parts of fructus amomi, 10-15 parts of red paeony root, 10-15 parts of sandalwood, 10-15 parts of fructus aurantii, 20-25 parts of radix bupleuri, 30-35 parts of radix curcumae, 20-25 parts of rhizoma corydalis, 10-15 parts of codonopsis pilosula and 30-35 parts of radix ophiopogonis.
2. The traditional Chinese medicine preparation for treating myocardial ischemia according to claim 1, which is characterized in that: the raw materials of the various medicinal preparations comprise, by weight, 5 parts of panax notoginseng saponins, 10 parts of salvianolate, 5 parts of ligustrazine, 10 parts of ginseng, 5 parts of leech, 10 parts of frankincense, 20 parts of borneol, 20 parts of spina date seed, 10 parts of calculus bovis factitius, 10 parts of angelica, 10 parts of astragalus, 10 parts of musk, 15 parts of toad venom, 10 parts of dragon's blood, 10 parts of caulis spatholobi, 10 parts of corydalis tuber, 30 parts of polygonum multiflorum, 20 parts of rhizoma polygonati, 15 parts of radix puerariae, 10 parts of elecampane, 40 parts of donkey-hide gelatin, 20 parts of water caltrop skin, 10 parts of allium macrostemon, 15 parts of rhizoma pinelliae preparata, 20 parts of semen coicis, 30 parts of pericarpium citri reticulatae, 20 parts of poria cocos, 10 parts of fructus amomi, 10 parts of red paeony root, 10 parts.
3. The traditional Chinese medicine preparation for treating myocardial ischemia according to claim 1, which is characterized in that: the raw materials of the various medicinal preparations comprise, by weight, 6 parts of panax notoginseng saponins, 11 parts of salvianolate, 6 parts of ligustrazine, 11 parts of ginseng, 6 parts of leech, 11 parts of frankincense, 21 parts of borneol, 21 parts of spina date seed, 11 parts of calculus bovis factitius, 11 parts of angelica, 11 parts of astragalus, 11 parts of musk, 16 parts of toad venom, 11 parts of dragon's blood, 11 parts of caulis spatholobi, 11 parts of corydalis tuber, 31 parts of polygonum multiflorum, 21 parts of rhizoma polygonati, 16 parts of radix puerariae, 11 parts of elecampane, 41 parts of donkey-hide gelatin, 21 parts of water caltrop skin, 11 parts of allium macrostemon, 16 parts of rhizoma pinelliae preparata, 21 parts of semen coicis, 31 parts of dried orange peel, 21 parts of poria cocos, 11 parts of fructus amomi, 11 parts of red paeony root, 11 parts of sandal.
4. The traditional Chinese medicine preparation for treating myocardial ischemia according to claim 1, which is characterized in that: the raw materials of the various medicinal preparations comprise, by weight, 7 parts of panax notoginseng saponins, 12 parts of salvianolate, 7 parts of ligustrazine, 12 parts of ginseng, 7 parts of leech, 12 parts of frankincense, 22 parts of borneol, 22 parts of spina date seed, 12 parts of calculus bovis factitius, 12 parts of angelica, 12 parts of astragalus, 12 parts of musk, 17 parts of toad venom, 12 parts of dragon's blood, 12 parts of caulis spatholobi, 12 parts of corydalis tuber, 32 parts of polygonum multiflorum, 22 parts of rhizoma polygonati, 17 parts of radix puerariae, 12 parts of elecampane, 42 parts of donkey-hide gelatin, 22 parts of water caltrop skin, 12 parts of allium macrostemon, 17 parts of rhizoma pinelliae preparata, 22 parts of semen coicis, 32 parts of pericarpium citri reticulatae, 22 parts of poria cocos, 12 parts of fructus amomi, 12 parts of red paeony root, 12 parts.
5. The traditional Chinese medicine preparation for treating myocardial ischemia according to claim 1, which is characterized in that: the raw materials of the various medicinal preparations comprise, by weight, 8 parts of panax notoginseng saponins, 13 parts of salvianolate, 8 parts of ligustrazine, 13 parts of ginseng, 8 parts of leech, 13 parts of frankincense, 23 parts of borneol, 23 parts of spina date seed, 13 parts of calculus bovis factitius, 13 parts of angelica, 13 parts of astragalus, 13 parts of musk, 18 parts of toad venom, 13 parts of dragon's blood, 13 parts of caulis spatholobi, 13 parts of corydalis tuber, 33 parts of polygonum multiflorum, 23 parts of rhizoma polygonati, 18 parts of radix puerariae, 13 parts of elecampane, 43 parts of donkey-hide gelatin, 23 parts of water caltrop skin, 13 parts of allium macrostemon, 18 parts of rhizoma pinelliae preparata, 23 parts of semen coicis, 33 parts of dried orange peel, 23 parts of poria cocos, 13 parts of fructus amomi, 13 parts of red paeony root, 13 parts of sandal.
6. The traditional Chinese medicine preparation for treating myocardial ischemia according to claim 1, which is characterized in that: the raw materials of the various medicinal preparations comprise, by weight, 9 parts of panax notoginseng saponins, 14 parts of salvianolate, 9 parts of ligustrazine, 14 parts of ginseng, 9 parts of leech, 14 parts of frankincense, 24 parts of borneol, 24 parts of spina date seed, 14 parts of calculus bovis factitius, 14 parts of angelica, 14 parts of astragalus, 14 parts of musk, 19 parts of toad venom, 14 parts of dragon's blood, 14 parts of caulis spatholobi, 14 parts of corydalis tuber, 34 parts of polygonum multiflorum, 24 parts of rhizoma polygonati, 19 parts of radix puerariae, 14 parts of elecampane, 44 parts of donkey-hide gelatin, 24 parts of water caltrop skin, 14 parts of allium macrostemon, 19 parts of rhizoma pinelliae preparata, 24 parts of semen coicis, 34 parts of pericarpium citri reticulatae, 24 parts of poria cocos, 14 parts of fructus amomi, 14 parts of red paeony root, 14 parts.
7. The traditional Chinese medicine preparation for treating myocardial ischemia according to claim 1, which is characterized in that: the raw materials of the various medicinal preparations comprise, by weight, 10 parts of panax notoginseng saponins, 15 parts of salvianolate, 10 parts of ligustrazine, 15 parts of ginseng, 10 parts of leech, 15 parts of frankincense, 25 parts of borneol, 25 parts of spina date seed, 15 parts of calculus bovis factitius, 15 parts of angelica, 15 parts of astragalus, 15 parts of musk, 20 parts of toad venom, 15 parts of dragon's blood, 15 parts of caulis spatholobi, 15 parts of corydalis tuber, 35 parts of polygonum multiflorum, 25 parts of rhizoma polygonati, 20 parts of radix puerariae, 15 parts of elecampane, 45 parts of donkey-hide gelatin, 25 parts of water caltrop peel, 15 parts of allium macrostemon, 20 parts of rhizoma pinelliae preparata, 25 parts of semen coicis, 35 parts of pericarpium citri reticulatae, 25 parts of poria cocos, 15 parts of fructus amomi, 15 parts of red paeony root, 15 parts.
CN202011263600.9A 2020-11-12 2020-11-12 Traditional Chinese medicine preparation for treating myocardial ischemia Pending CN112451637A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011263600.9A CN112451637A (en) 2020-11-12 2020-11-12 Traditional Chinese medicine preparation for treating myocardial ischemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011263600.9A CN112451637A (en) 2020-11-12 2020-11-12 Traditional Chinese medicine preparation for treating myocardial ischemia

Publications (1)

Publication Number Publication Date
CN112451637A true CN112451637A (en) 2021-03-09

Family

ID=74826618

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011263600.9A Pending CN112451637A (en) 2020-11-12 2020-11-12 Traditional Chinese medicine preparation for treating myocardial ischemia

Country Status (1)

Country Link
CN (1) CN112451637A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1328829A (en) * 2000-06-16 2002-01-02 秦中凯 Medicine for curing angiocardiopathy
CN101342238A (en) * 2008-08-27 2009-01-14 吉林华康药业股份有限公司 Medicinal composition for treating cardiovascular and cerebrovascular diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1328829A (en) * 2000-06-16 2002-01-02 秦中凯 Medicine for curing angiocardiopathy
CN101342238A (en) * 2008-08-27 2009-01-14 吉林华康药业股份有限公司 Medicinal composition for treating cardiovascular and cerebrovascular diseases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘建勋: "《中华医学百科全书•中药药理学》", 31 January 2020 *
刘相敏等: "益气活血法治疗老年心肌缺血的临床观察", 《中国医药导报》 *
彭成等: "《中药药理学》", 31 August 2018 *
陈信云等: "《中药学》", 31 January 2017 *

Similar Documents

Publication Publication Date Title
CN103071128B (en) Externally-applied plaster for curing dysmenorrhea
CN100591352C (en) Traditional Chinese medicine for treating nerve function coloboma due to injury of brain and brain surgery and its preparation method
CN104147462B (en) A kind of medicine for treating psoriasis vulgaris
CN102698058B (en) Health care extract for adjusting sub-healthy state of human body
CN1046421C (en) Drug for curing pulmonary tuberculosis
CN101062263A (en) Medicine for treating coronary heart disease
CN102526189B (en) Chinese medicinal composition for treating angina pectoris
CN105796789A (en) Traditional Chinese medicine preparation for treating coronary heart disease
CN103933280A (en) Traditional Chinese medicine composition for treating PCI (percutanecus coronary intervention) postoperative angina of phlegm-obstructing heart vessel type coronary heart disease and application thereof
CN112451637A (en) Traditional Chinese medicine preparation for treating myocardial ischemia
CN103990009A (en) Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness
CN102600251B (en) Rheumatism-rehabilitating traditional Chinese formulation
CN105362797A (en) Traditional Chinese medicine for treating myocarditis
CN104888133A (en) Traditional Chinese medicine composition for treatment of coronary heart disease
CN104623605A (en) Traditional Chinese medicine capable of treating breast cancer
CN1294961C (en) Oral liquid for curing myocardial ischemia and process for preparing the same
CN101085303A (en) Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN114272329B (en) Traditional Chinese medicine composition for treating liver and kidney deficiency type cervical spondylosis, preparation and application
CN100406035C (en) Chinese medicine preparation for treating protrasion of lumbar intervertebral disc
CN107693621A (en) Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment
CN101366910B (en) Traditional Chinese medicine for treating frequent premature beat
CN1158095C (en) Chinese medicine for treating rheumatoid arthritis
CN105194526A (en) Traditional Chinese medicine for treating hepatic calculi
CN103735898A (en) Chinese herbal medicine formula for treating myocarditis and preparation method thereof
CN116077573A (en) Traditional Chinese medicine for dredging channels and collaterals and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210309